Two- vs three-drug combination chemotherapy in advanced or recurrent head and neck cancer: A single institution experience of 361 patients

Author: Pai V.   Mazumdar T.   Deshmukh C.   Bakshi A.   Parikh D.   Parikh P.   Mistry R.   Pathak K.   D’Cruz A.  

Publisher: Humana Press, Inc

ISSN: 1357-0560

Source: Medical Oncology, Vol.21, Iss.4, 2004-12, pp. : 305-308

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content